NO20012100D0 - Pyrano-, piperidino- og tiopyranoforbindelser og fremgangsmåter ved anvendelse - Google Patents
Pyrano-, piperidino- og tiopyranoforbindelser og fremgangsmåter ved anvendelseInfo
- Publication number
- NO20012100D0 NO20012100D0 NO20012100A NO20012100A NO20012100D0 NO 20012100 D0 NO20012100 D0 NO 20012100D0 NO 20012100 A NO20012100 A NO 20012100A NO 20012100 A NO20012100 A NO 20012100A NO 20012100 D0 NO20012100 D0 NO 20012100D0
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- thiopyrano
- pyrano
- piperidino
- methods
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 title 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 230000008602 contraction Effects 0.000 abstract 1
- 230000002102 hyperpolarization Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 108020001213 potassium channel Proteins 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18169098A | 1998-10-28 | 1998-10-28 | |
| US09/421,862 US6191140B1 (en) | 1998-10-28 | 1999-10-20 | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| PCT/US1999/025373 WO2000024743A1 (en) | 1998-10-28 | 1999-10-28 | Pyrano, piperidino, and thiopyrano compounds and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20012100D0 true NO20012100D0 (no) | 2001-04-27 |
| NO20012100L NO20012100L (no) | 2001-06-14 |
| NO318628B1 NO318628B1 (no) | 2005-04-18 |
Family
ID=26877422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012100A NO318628B1 (no) | 1998-10-28 | 2001-04-27 | Pyrano-, piperidino- og tiopyranoforbindelser, farmasoytiske sammensetninger inneholdende det samme og anvendelse av forbindelsene |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6191140B1 (no) |
| EP (1) | EP1124828B1 (no) |
| JP (1) | JP2002528454A (no) |
| KR (1) | KR20010085975A (no) |
| CN (1) | CN1335846A (no) |
| AT (1) | ATE382620T1 (no) |
| AU (1) | AU764163B2 (no) |
| BG (1) | BG105524A (no) |
| BR (1) | BR9914688A (no) |
| CA (1) | CA2348576A1 (no) |
| CZ (1) | CZ20011480A3 (no) |
| DE (1) | DE69937895T2 (no) |
| ES (1) | ES2299272T3 (no) |
| HK (1) | HK1041877A1 (no) |
| HU (1) | HUP0104146A3 (no) |
| NO (1) | NO318628B1 (no) |
| NZ (1) | NZ511041A (no) |
| PL (1) | PL347552A1 (no) |
| SK (1) | SK5242001A3 (no) |
| TR (1) | TR200101140T2 (no) |
| WO (1) | WO2000024743A1 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
| US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| US6642222B2 (en) * | 1998-10-28 | 2003-11-04 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| MXPA02001207A (es) * | 1999-08-03 | 2002-07-30 | Abbott Lab | Abridores de canal de potasio. |
| US6538004B2 (en) * | 2000-03-03 | 2003-03-25 | Abbott Laboratories | Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| EP1307429B1 (en) | 2000-08-02 | 2007-11-28 | AstraZeneca AB | Process for asymmetric synthesis of substituted 1,4-dihydropyridines |
| US6632418B2 (en) * | 2001-07-30 | 2003-10-14 | Abbott Laboratories | Radioligands and their use for identifying potassium channel modulators |
| WO2003011869A1 (en) * | 2001-07-30 | 2003-02-13 | Abbott Laboratories | Radioligands and their use for identifying potassium channel modulators |
| US20030153773A1 (en) * | 2002-02-14 | 2003-08-14 | Wayne Gregory S. | Process for the production of dihydropyridines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4321384A (en) | 1981-02-27 | 1982-03-23 | American Home Products Corporation | Antihypertensive agents |
| DE3169626D1 (en) | 1981-02-27 | 1985-05-02 | American Home Prod | Antihypertensive agents |
| US4551534A (en) | 1984-03-30 | 1985-11-05 | American Home Products Corporation | Aralkyl or aryloxyalkyl 1,7-naphthyridine-3-carboxylic acid esters |
| US4618678A (en) | 1985-07-29 | 1986-10-21 | American Home Products Corporation | 4-(2,3-dichloro-6-fluorophenyl)-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-1,7-naphthyridine-3-carboxylic acid 2-(2,3-dichlorophenoxy)ethyl ester |
| AU6042686A (en) | 1985-07-29 | 1987-02-05 | American Home Products Corporation | 1,4,5,6,7,8-hexahydro-(substituted) phenyl-1,7- napthyridine-3-carboxylic acid derivatives |
| US4596873A (en) | 1985-07-29 | 1986-06-24 | American Home Products Corporation | 1,4,5,6,7,8-Hexahydro-2-alkyl-4-aryl-5-oxo-1,7-naphthyridine-3-carboxylic acid aromatic esters and pharmaceutically acceptable acid addition salts thereof useful as antihypertensive agents |
| EP0539154B1 (en) | 1991-10-21 | 1997-12-29 | Zeneca Limited | Acridine-1,8-dione-derivatives as therapeutic agents |
| GB9220570D0 (en) | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
| GB9318935D0 (en) | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
| DE4424678A1 (de) | 1994-07-13 | 1996-01-18 | Bayer Ag | Dioxo-thiopyrano-pyridin-carbonsäure-derivate |
| DE69823227T2 (de) * | 1997-12-18 | 2005-03-10 | Abbott Laboratories, Abbott Park | Kaliumkanalöffner |
| US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| HK1041878A1 (zh) * | 1998-10-28 | 2002-07-26 | Abbott Laboratories | 二羟吡啶化合物和其用作钾通道开放剂的用途 |
-
1999
- 1999-10-20 US US09/421,862 patent/US6191140B1/en not_active Expired - Fee Related
- 1999-10-28 HK HK02101208.4A patent/HK1041877A1/zh unknown
- 1999-10-28 JP JP2000578313A patent/JP2002528454A/ja active Pending
- 1999-10-28 EP EP99960168A patent/EP1124828B1/en not_active Expired - Lifetime
- 1999-10-28 AU AU17095/00A patent/AU764163B2/en not_active Ceased
- 1999-10-28 KR KR1020017005347A patent/KR20010085975A/ko not_active Ceased
- 1999-10-28 WO PCT/US1999/025373 patent/WO2000024743A1/en not_active Ceased
- 1999-10-28 SK SK524-2001A patent/SK5242001A3/sk unknown
- 1999-10-28 HU HU0104146A patent/HUP0104146A3/hu unknown
- 1999-10-28 CA CA002348576A patent/CA2348576A1/en not_active Abandoned
- 1999-10-28 BR BR9914688-6A patent/BR9914688A/pt not_active IP Right Cessation
- 1999-10-28 NZ NZ511041A patent/NZ511041A/xx unknown
- 1999-10-28 TR TR2001/01140T patent/TR200101140T2/xx unknown
- 1999-10-28 DE DE69937895T patent/DE69937895T2/de not_active Expired - Lifetime
- 1999-10-28 CN CN99815020A patent/CN1335846A/zh active Pending
- 1999-10-28 ES ES99960168T patent/ES2299272T3/es not_active Expired - Lifetime
- 1999-10-28 PL PL99347552A patent/PL347552A1/xx not_active Application Discontinuation
- 1999-10-28 AT AT99960168T patent/ATE382620T1/de not_active IP Right Cessation
- 1999-10-28 CZ CZ20011480A patent/CZ20011480A3/cs unknown
-
2001
- 2001-04-27 NO NO20012100A patent/NO318628B1/no not_active IP Right Cessation
- 2001-05-19 BG BG105524A patent/BG105524A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000024743A1 (en) | 2000-05-04 |
| ES2299272T3 (es) | 2008-05-16 |
| BG105524A (bg) | 2001-12-29 |
| NZ511041A (en) | 2003-03-28 |
| CA2348576A1 (en) | 2000-05-04 |
| HUP0104146A2 (hu) | 2002-04-29 |
| TR200101140T2 (tr) | 2002-07-22 |
| HUP0104146A3 (en) | 2002-10-28 |
| CN1335846A (zh) | 2002-02-13 |
| PL347552A1 (en) | 2002-04-08 |
| EP1124828A1 (en) | 2001-08-22 |
| NO318628B1 (no) | 2005-04-18 |
| BR9914688A (pt) | 2001-10-02 |
| AU1709500A (en) | 2000-05-15 |
| AU764163B2 (en) | 2003-08-14 |
| HK1041877A1 (zh) | 2002-07-26 |
| KR20010085975A (ko) | 2001-09-07 |
| SK5242001A3 (en) | 2001-12-03 |
| JP2002528454A (ja) | 2002-09-03 |
| NO20012100L (no) | 2001-06-14 |
| CZ20011480A3 (cs) | 2001-08-15 |
| EP1124828B1 (en) | 2008-01-02 |
| ATE382620T1 (de) | 2008-01-15 |
| DE69937895D1 (de) | 2008-02-14 |
| DE69937895T2 (de) | 2009-01-02 |
| US6191140B1 (en) | 2001-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9900100D0 (sv) | New compounds | |
| MXPA01009972A (es) | Celda de electrolito no acuosa. | |
| MXPA01009973A (es) | Celda de electrolito solido. | |
| HK1052346A1 (zh) | 有效用作β-2-肾上腺素受体激动剂以及PDE4-抑制剂的化合物 | |
| EP1828284A4 (en) | SULPONATED MULTIBLOCK COPOLYMER AND ELECTROLYTE MEMBRANE THEREWITH | |
| GB9929552D0 (en) | Compounds | |
| MXPA02012659A (es) | Derivados de pirazindiona condensados. | |
| DE60019121D1 (de) | Kaliumkanäleöffner | |
| NO20012100L (no) | Pyrano-, piperidino- og tiopyranoforbindelser og fremgangsmåter ved anvendelse | |
| NO20011209L (no) | Batteri med fast-elektrolytt og fremgangsmåte til fremstilling av dette | |
| CA2412596A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
| MXPA02012472A (es) | Compuestos quimicos. | |
| MXPA02010806A (es) | Compuestos de pirano, piperidino y tiopirano y metodos de uso. | |
| WO2005001042A3 (en) | Smooth muscle progenitor cells | |
| NO991734L (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
| DE50103547D1 (de) | Verwendung von sekundärem zellwandpolymer prokaryontischer mikroorganismen | |
| WO2000064422A3 (en) | Novel treatment of neurotraumatic conditions with raf inhibitor | |
| EP1330267A4 (en) | OLFACTORY NEURON CULTURES, METHODS OF MAKING AND USING | |
| AU2001269081A1 (en) | Electrochemical cells | |
| AU2001287428A1 (en) | Gas-evolving electrochemical cells | |
| GB0229261D0 (en) | Cells,culture methods and their uses | |
| AU2001285637A1 (en) | Electrochemical cell, use of the electrochemical cell, and method for electrolytically contacting and electrochemically influencing surfaces | |
| AU2002225011A1 (en) | Method for improving the water balance of fuel cells | |
| WO1997030354A3 (en) | Foetal cell analysis | |
| WO2003076588A8 (en) | Multiplexed cell transfection using coded carriers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |